Sanofi (NYSE : SNY)
today announced that its US Consumer Healthcare Division, Chattem, Inc.,
completed the acquisition of the worldwide rights to the Rolaids^® brand from
McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.
Loading...
Loading...
JNJJohnson & Johnson
$156.030.07%
Edge Rankings
Momentum
56.72
Growth
48.22
Quality
15.33
Value
24.70
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.